Request Your Free Webinar Now:

"Registries: Supercharging Real-World Evidence for Drug Development and Approval"

The use of real-world evidence (RWE) in drug development has been fueled by an increased acceptance of RWE by stakeholders such as regulatory agencies, health technology assessment bodies, and payers, as well as a plethora of real-world data (RWD) sources.

Discover how protocol-driven disease registries—purpose-built for research—serve as one of the most clinically rich sources of real-world data (RWD). Explore how these registries are used to efficiently fulfill post-approval safety commitments, monitor treatment patterns, and describe the natural history of diseases, while uncovering best practices for selecting the right registry for your research needs.

Offered Free by: Evidera
See All Resources from: Evidera